[Clinicopathological features of rhabdomyosarcoma with TFCP2 fusions].

Chen, X Y; Chen, G; Zhu, Q; Zhu, W F; He, C; Huang, R F

Chen, X Y; Chen, G; Zhu, Q; Zhu, W F; He, C; Huang, R F.

Afiliação

Chen XY; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
Chen G; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
Zhu Q; Department of Molecular Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
Zhu WF; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
He C; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.
Huang RF; Department of Pathology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China.

Zhonghua Bing Li Xue Za Zhi ; 51(6): 545-547, 2022 Jun 08.

Article em Zh | MEDLINE | ID: mdl-35673728

Assuntos

Rabdomiossarcoma Embrionário; Rabdomiossarcoma; Proteínas de Ligação a DNA; Humanos; Rabdomiossarcoma/genética; Fatores de Transcrição

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rabdomiossarcoma / Rabdomiossarcoma Embrionário Limite: Humans Idioma: Zh Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google